Gert De Meerleer
Katholieke Universiteit Leuven
CancerInternal medicineRadiologyUrologySurgeryMagnetic resonance imagingOncologyExternal beam radiotherapyProstateBiochemical recurrenceAndrogen deprivation therapyMetastasisProstatectomyProstate cancerLymph nodeProstate-specific antigenToxicityNuclear medicineRadiation therapyMedicine
190Publications
36H-index
4,757Citations
Publications 198
Newest
Source
#2Lindsay Poppe (Ghent University Hospital)
BACKGROUND The outcome of patients with muscle-invasive bladder cancer (MIBC) remains poor, despite aggressive treatments. Inadequate primary staging, classically performed by computed tomography (CT)-imaging, could lead to inappropriate treatment and might contribute to these poor results. Although not (yet) adapted by international guidelines, several reports have indicated the superiority of 18F-fluorodeoxyglucose-positron emission tomography-CT (18F-FDG-PET-CT) compared to CT in the detectio...
Source
#7Benjamin Ayres (St George’s University Hospitals NHS Foundation Trust)H-Index: 5
BACKGROUND Data on the impact of human papillomavirus (HPV) infection status and outcomes for perioperative treatments for patients with lymph node-involved penile squamous-cell carcinoma (PSCC) are lacking. OBJECTIVE To analyze the benefit from perioperative radiotherapy (RT) for PSCC according to HPV infection status. DESIGN, SETTING, AND PARTICIPANTS In an international multicenter database of 1254 patients with PSCC who received inguinal lymph node dissection (ILND), 507 had suitable clinica...
Source
#1Gaëtan Devos (Katholieke Universiteit Leuven)H-Index: 6
#2Wout Devlies (Katholieke Universiteit Leuven)H-Index: 3
Last. Wouter Everaerts (Katholieke Universiteit Leuven)H-Index: 23
view all 12 authors...
Patients with high-risk prostate cancer treated with curative intent are at an increased risk of biochemical recurrence, metastatic progression and cancer-related death compared with patients treated for low-risk or intermediate-risk disease. Thus, these patients often need multimodal therapy to achieve complete disease control. Over the past two decades, multiple studies on the use of neoadjuvant treatment have been performed using conventional androgen deprivation therapy, which comprises lute...
Source
#1Nicola FossatiH-Index: 44
#2Giovanni MotterleH-Index: 6
Last. Alessandro NiniH-Index: 14
view all 26 authors...
INTRODUCTION AND OBJECTIVE:Salvage lymph node dissection (SLND) is considered an experimental treatment for patients with nodal recurrence after radical prostatectomy (RP). However, most of them al...
Source
#1Elio MazzoneH-Index: 15
#2Giorgio GandagliaH-Index: 55
Last. R. Jeffrey KarnesH-Index: 72
view all 25 authors...
Source
#1Gert De Meerleer (Katholieke Universiteit Leuven)H-Index: 36
#2Charlien Berghen (Katholieke Universiteit Leuven)H-Index: 5
Last. Kato Rans (Katholieke Universiteit Leuven)H-Index: 2
view all 13 authors...
In patients with prostate cancer who have a high risk of pelvic nodal disease, the use of elective whole pelvis radiotherapy is still controversial. Two large, randomised, controlled trials (RTOG 9413 and GETUG-01) did not show a benefit of elective whole pelvis radiotherapy over prostate-only radiotherapy. In 2020, the POP-RT trial established the role of elective whole pelvis radiotherapy in patients who have more than a 35% risk of lymph node invasion (known as the Roach formula). POP-RT stre...
Source
Source
#3Nicola FossatiH-Index: 44
#4Alberto BrigantiH-Index: 99
Last. Hendrik Van PoppelH-Index: 83
view all 14 authors...
Source
#1Daimantas MilonasH-Index: 7
#2Lorenzo ToscoH-Index: 13
Last. Rafael Sanchez-SalasH-Index: 27
view all 17 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.